Biogenix had an inception in April 2020, and has been uniquely positioned to drive holistic testing capabilities, to develop and deploy holistic and scalable healthcare diagnostic solutions for UAE residents. We have been known for strict adherence to national and international standards and benchmarks like DOH standards and ISO15189. We designed, built and mobilized the UAE’s first COVID-19 dedicated detection lab within 15 days. In this state-of-the-art laboratories we process tens of thousands of RT-PCR tests per day and is the first in the world of this scale to be operational outside China. The lab showcases the commitment of G42 to support the UAE government to combat the COVID-19 pandemic. Our major clients across government and private entities trusted us to deliver within stringent timelines, with an outreach of 600,000 customers across UAE. Biogenix Labs, as a part of G42 Healthcare, have an exciting program of activity to support the health of future generations. We partner extensively with leading international players who complement our ecosystem and support delivery of our mandates. We have the widest test menu and panels in the disciplines of Molecular Diagnostics, clinical biochemistry, clinical immunology, metabolic testing, hormonal analysis, hematology including Flow Cytometry, Immunophenotying, Cytogenetics, Histopathology and Cytology. Biogenix has internationally accepted external and internal quality assurance programs in place. With a dedicated staff of more than 150 lab and quality experts, shortest turn around of 2 hours and uniquely located in sustainable city of Masdar, Biogenix is changing the landscape and meaning of reference laboratories. Our state of the art equipment and processes include fully automated extractors, real time PCR, liquid handlers, immuno-assay, chemistry and hematology analyzers. Biogenix lab has achieved the first COVID-19 ISO15189 accreditation in the UAE. We are Biogenix Labs.